127 related articles for article (PubMed ID: 15949741)
21. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
Nishibu A; Sakai E; Oyama N; Yamamoto T
Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
[TBL] [Abstract][Full Text] [Related]
22. Bosentan for the treatment of adult pulmonary hypertension.
Dwyer N; Kilpatrick D
Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
[TBL] [Abstract][Full Text] [Related]
23. Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study.
Kaluski E; Cotter G; Leitman M; Milo-Cotter O; Krakover R; Kobrin I; Moriconi T; Rainisio M; Caspi A; Reizin L; Zimlichman R; Vered Z
Cardiology; 2008; 109(4):273-80. PubMed ID: 17873492
[TBL] [Abstract][Full Text] [Related]
24. [Right ventricular insufficiency in patients in the early periods after orthotopic transplantation of donor heart].
Eremenko AA; Lebedeva RN; Zhigareva EIu; Chaus NI
Anesteziol Reanimatol; 1994; (5):12-4. PubMed ID: 7893066
[TBL] [Abstract][Full Text] [Related]
25. [Current recommendations for the diagnosis and treatment of pulmonary hypertension].
Olschewski H
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S334-7. PubMed ID: 17139601
[TBL] [Abstract][Full Text] [Related]
26. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
[TBL] [Abstract][Full Text] [Related]
27. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
28. [Therapy of primary pulmonary hypertension].
Höper MM; Wagner TO; Fabel H
Dtsch Med Wochenschr; 1993 Dec; 118(49):1809-13. PubMed ID: 8253044
[No Abstract] [Full Text] [Related]
29. Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension).
Wilson SR; Ghio S; Scelsi L; Horn EM
Prog Cardiovasc Dis; 2012; 55(2):104-18. PubMed ID: 23009907
[TBL] [Abstract][Full Text] [Related]
30. Atrial septal defect repair after a 10-month treatment with bosentan in a patient with severe pulmonary arterial hypertension: a case report.
Hoetzenecker K; Ankersmit HJ; Bonderman D; Hoetzenecker W; Seitelberger R; Klepetko W; Lang IM
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):760-1. PubMed ID: 19258107
[No Abstract] [Full Text] [Related]
31. Complex multidrug therapy in a patient with pulmonary hypertension before and after orthotopic heart transplantation. A case report.
D'Alto M; Alfano D; Maiello C; Sarubbi B; Santoro G; Argiento P; Galdieri N; Russo MG; Cotrufo M; Calabrò R
J Cardiovasc Med (Hagerstown); 2007 Nov; 8(11):950-2. PubMed ID: 17906484
[TBL] [Abstract][Full Text] [Related]
32. [Special anesthesia care in heart transplantation. The management of right ventricular failure].
Gómez-Arnau J; Planas A; Lora-Tamayo JI; Martínez MV
Rev Esp Cardiol; 1995; 48 Suppl 7():60-4. PubMed ID: 8775818
[TBL] [Abstract][Full Text] [Related]
33. Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy.
Schulze-Neick I; Gilbert N; Ewert R; Witt C; Gruenig E; Enke B; Borst MM; Lange PE; Hoeper MM
Am Heart J; 2005 Oct; 150(4):716. PubMed ID: 16209972
[TBL] [Abstract][Full Text] [Related]
34. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.
Hoeper MM; Granton J
Am J Respir Crit Care Med; 2011 Nov; 184(10):1114-24. PubMed ID: 21700906
[TBL] [Abstract][Full Text] [Related]
35. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary hypertension].
Kucewicz E; Wojarski J; Goliszek L; Pacholewicz J; Nowak J; Maciejewski T; Puzio J
Anestezjol Intens Ter; 2009; 41(1):51-5. PubMed ID: 19517679
[TBL] [Abstract][Full Text] [Related]
37. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device.
Imamura T; Kinugawa K; Hatano M; Kato N; Minatsuki S; Muraoka H; Inaba T; Maki H; Shiga T; Yao A; Kyo S; Ono M; Nagai R
J Artif Organs; 2013 Mar; 16(1):101-4. PubMed ID: 23015200
[TBL] [Abstract][Full Text] [Related]
38. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.
Hoeper MM; Benza RL; Corris P; de Perrot M; Fadel E; Keogh AM; Kühn C; Savale L; Klepetko W
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545979
[TBL] [Abstract][Full Text] [Related]
39. Left Ventricular Dysfunction After Lung Transplantation for Pulmonary Arterial Hypertension.
Gupta S; Torres F; Bollineni S; Mohanka M; Kaza V
Transplant Proc; 2015 Nov; 47(9):2732-6. PubMed ID: 26680083
[TBL] [Abstract][Full Text] [Related]
40. [RV meets LV - "State-of-the-Art"].
Rosenkranz S
Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S18-9. PubMed ID: 26069041
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
